Drug companies like it when the generic name sounds terrible and the brand name sounds nice.

Generic names have to be approved by two independent authorities and are chosen to improve safety by avoiding mixups and to suggest their function and relationship to other drugs. They are deliberately not very similar to the brand name.

https://www.latimes.com/business/lazarus/la-fi-lazarus-drug-... https://www.pfizer.com/news/articles/ever_wonder_how_drugs_a...

So, good or bad, not really in the hands of drug makers.

Its just the pharmaceutical drug name, similar to Semaglutide with brand name Ozempic/Wegovy. It'll have a brand name once its launched on the market.

As others have said, it’s the generic name, not brand name. I like it, because I generally focus on memorizing generic names over brand names personally. I know that anything ending in -tide is a peptide and highly likely these days to be a modifier of the GLP system.

Other drugs in the same family as retatrutide include tirzepatide (“Mounjaro”), and semaglutide (“Wegovy”). In that light, it’s a pretty good name!